Attribute Cm News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Attribute Cm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Attribute Cm Today - Breaking & Trending Today

Bridgebio seeks Japan approval of acoramidis for rare heart disease

Published: February 6, 2024

Armed with strong phase III safety data in Japanese patients, Palo Alto, Calif.-based Bridgebio Pharma Inc. is planning to file for Japan approval of its investigational drug acoramidis for a rare heart disorder.

Source: bioworld.com

Related Topics:

Pharma IncPalo AltoBridgebio PharmaBridgebio Pharma IncAsia PacificAttr CmTransthyretin Meditated Amyloid CardiomyopathyPfizer IncAttribute CmPhase IiiSafety DataAlnylam Pharmaceuticals IncIonis Pharmaceuticals IncAstrazeneca PlcIntellia Therapeutics IncNtla 2001Transthyretin Amyloid CardiomyopathyBioworld Asia